Do Physicians’ Attitudes toward Implantable Cardioverter Defibrillator Therapy Vary by Patient Age, Gender, or Race?

Alkhatib, Mohammad; Sanders, Gillian D; O’Brien, Sean M.; Matlock, Daniel D.; Zimmer, Michelle; Masoudi, Mansoureh; Peterson, Michael

doi:10.1111/j.1542-474x.2010.00412.x

Cited by 14 publications

(5 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Complete details of the survey and procedures have been discussed previously. 7 We asked: “To what extent does each of the following factors affect your recommendations regarding an ICD for primary prevention of sudden cardiac death?” To minimize social desirability bias in responses, we included both mortality benefits and patient preferences with 12 other factors that might influence the decision. Responses were scored on a 5-point Likert scale from “not at all” (scored 0) to “a great deal” (scored 4).…”

Section: Methodsmentioning

confidence: 99%

Patient Preference in the Decision to Place Implantable Cardioverter-Defibrillators

Caverly¹,

Al‐Khatib²,

Kutner³

et al. 2012

Arch Intern Med

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Methodsmentioning

confidence: 99%

Patient Preference in the Decision to Place Implantable Cardioverter-Defibrillators

Caverly¹,

Al‐Khatib²,

Kutner³

et al. 2012

Arch Intern Med

Self Cite

View full text Add to dashboard Cite

show abstract

“…14,15 In a survey of practicing cardiologists in the U.S., health care providers were not less likely to recommend an ICD to women and racial minorities, but they were less likely to recommend it to older patients. 16 Although this may reflect hesitation regarding offering an ICD to patients who are frail and have several comorbidities, this has not been confirmed by that or other studies. Therefore, disparities in ICD use in older patients should be examined.…”

Section: Professional Societies/ Researchersmentioning

confidence: 88%

Future Research Prioritization: Implantable Cardioverter-Defibrillator Therapy in Older Patients

et al. 2015

Self Cite

View full text Add to dashboard Cite

BACKGROUND: Although the implantable cardioverterdefibrillator (ICD) is highly effective therapy for preventing sudden cardiac death, there is considerable uncertainty about its benefits and harms in older patients, especially in the presence of factors, other than old age, that increase the risk of death. OBJECTIVE: To develop a prioritized research agenda for the Patient-Centered Outcomes Research Institute as informed by a diverse group of stakeholders on the use and outcomes of the ICD in older patients. DESIGN: The existing literature was reviewed to identify evidence gaps, which were then refined by engaged stakeholders. Using a forced-ranking prioritization method, the stakeholders ranked evidence gaps by importance. For the highest-ranked evidence gaps, relevant recent studies were identified using PubMed, and relevant ongoing trials were identified using ClinicalTrials.gov. PARTICIPANTS: Eighteen stakeholders, including clinical experts and researchers in the prevention of sudden cardiac death and ICD therapy, representatives from federal and non-governmental funding agencies, representatives from relevant professional societies, health care decision-makers and policymakers, and representatives from related consumer and patient advocacy groups KEY RESULTS: The top 12 evidence gaps prioritized by stakeholders were related to the safety and effectiveness of ICDs in older patient subgroups not well represented in clinical trials, predictors of SCD, the impact of the ICD on quality of life, the use of shared decision-making, disparities in ICD use, risk stratification strategies, patient preferences, and distribution of modes of death in older patients. CONCLUSIONS: In this paper, we identify evidence gaps of high priority for current and future investigations of ICD therapy. Addressing these gaps will likely resolve many of the uncertainties surrounding the use and outcomes of the ICD in older patients seen in clinical practice.KEY WORDS: stakeholder engagement; cardiovascular disease; decision making.

show abstract

“…A paper survey administered to roughly 10,000 physicians demonstrated no statistical difference in the rate of ICD referral based on patient race. 64 However, this study was conducted via paper survey rather than using real-life clinical data, which could meaningfully impact results. To that point, other studies have attempted to quantify bias in real world practice.…”

Section: Barriers To Uptakementioning

confidence: 99%

Racial and ethnic differences in implantable cardioverter-defibrillator patient selection, management, and outcomes

Kiernan¹,

Dodge²,

Kwaku³

et al. 2022

Heart Rhythm O2

View full text Add to dashboard Cite

Do Physicians’ Attitudes toward Implantable Cardioverter Defibrillator Therapy Vary by Patient Age, Gender, or Race?

Cited by 14 publications

References 16 publications

Patient Preference in the Decision to Place Implantable Cardioverter-Defibrillators

Patient Preference in the Decision to Place Implantable Cardioverter-Defibrillators

Future Research Prioritization: Implantable Cardioverter-Defibrillator Therapy in Older Patients

Racial and ethnic differences in implantable cardioverter-defibrillator patient selection, management, and outcomes

Contact Info

Product

Resources

About